PATENT CLAIM ANALYSIS

Application Number: 15963876
Application Type: Utility
Filing Date: 2018-04
Publication Date: 2018-11
Patent Classification: ["514", "211100"]

Abstract:
The present invention relates to crystalline polymorph forms of (S)-2-((2-((S)-4-(difluoromethyl)-2-oxooxazolidin-3-yl)-5,6-dihydrobenzo[f]imidazo[1,2-d][1,4]oxazepin-9-yl)amino)propanamide (GDC-0077), having the structure, Formula I: or stereoisomers, geometric isomers, tautomers, and pharmaceutically acceptable salts thereof, and processes of preparing the polymorph forms.

Claim (Index 4):
The Form A polymorph of  claim 1  characterized by the X-ray powder diffraction pattern substantially as shown in  FIG. 4 .

Metadata:
- Claim Count in Document: 27.0
- Percentile: 91.0
- Lexical Diversity: 1.5625
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['14570019', '14991658', '14009589', '16098435', '14639916']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7817307498504578
- 35 USC 102 Novelty (BERT): 0.5761303142341048
- Combined Prediction Score: 0.7611707062888224
- Mean Citation Score: 388.368112
- Max Citation Score: 482.6395
- Similarity Product: 360.8216158027053

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 0
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test